Cargando…

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis

BACKGROUND: DNA damage repair (DDR) plays a role in the tumorigenesis and progression of lung squamous cell carcinoma (LUSC), but the predictive value of DDR in LUSC has not been fully elucidated. METHODS: The LUSC datasets were retrieved from the Cancer Genome Atlas databases. Univariate Cox regres...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Bin, Gong, Ting, Sun, Bingsheng, Zhang, Zhenfa, Zhong, Diansheng, Wang, Changli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013644/
https://www.ncbi.nlm.nih.gov/pubmed/35293140
http://dx.doi.org/10.1111/1759-7714.14370
_version_ 1784688039304364032
author Jia, Bin
Gong, Ting
Sun, Bingsheng
Zhang, Zhenfa
Zhong, Diansheng
Wang, Changli
author_facet Jia, Bin
Gong, Ting
Sun, Bingsheng
Zhang, Zhenfa
Zhong, Diansheng
Wang, Changli
author_sort Jia, Bin
collection PubMed
description BACKGROUND: DNA damage repair (DDR) plays a role in the tumorigenesis and progression of lung squamous cell carcinoma (LUSC), but the predictive value of DDR in LUSC has not been fully elucidated. METHODS: The LUSC datasets were retrieved from the Cancer Genome Atlas databases. Univariate Cox regression and least absolute shrinkage and selection operator regression were integrated to identify critical genes and construct a DDR gene signature. We performed Kaplan–Meier (KM) curve to compare the overall survival (OS) between the two groups based on DDR signature and used the CIBERSORT tool to compare the immune cell composition. Further gene set enrichment analysis (GSEA) was performed on the differential expressed genes. RESULT: We established the DDR‐related gene signature on LUSC. KM curve showed the low‐risk group had a better prognosis than the high‐risk group in the training set (p = 0.022673) and the complete set (p = 0.003201). The area under receiver operating characteristic curve for OS was 0.98, 0.96, and 0.97 in the training dataset, testing dataset, and the complete dataset, respectively. The composition of immune cells was different between the high‐ and low‐risk group. The GSEA result suggests that genes of the patients in low‐risk group were mainly enriched in the DNA adducts; drug metabolism‐cytochrome P450, metabolism of xenobiotics by cytochrome P450. CONCLUSION: This study identified DDR‐associated potential biomarkers related to overall survival of LUSC and establishes the DDR‐associated gene signature.
format Online
Article
Text
id pubmed-9013644
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-90136442022-04-20 Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis Jia, Bin Gong, Ting Sun, Bingsheng Zhang, Zhenfa Zhong, Diansheng Wang, Changli Thorac Cancer Original Articles BACKGROUND: DNA damage repair (DDR) plays a role in the tumorigenesis and progression of lung squamous cell carcinoma (LUSC), but the predictive value of DDR in LUSC has not been fully elucidated. METHODS: The LUSC datasets were retrieved from the Cancer Genome Atlas databases. Univariate Cox regression and least absolute shrinkage and selection operator regression were integrated to identify critical genes and construct a DDR gene signature. We performed Kaplan–Meier (KM) curve to compare the overall survival (OS) between the two groups based on DDR signature and used the CIBERSORT tool to compare the immune cell composition. Further gene set enrichment analysis (GSEA) was performed on the differential expressed genes. RESULT: We established the DDR‐related gene signature on LUSC. KM curve showed the low‐risk group had a better prognosis than the high‐risk group in the training set (p = 0.022673) and the complete set (p = 0.003201). The area under receiver operating characteristic curve for OS was 0.98, 0.96, and 0.97 in the training dataset, testing dataset, and the complete dataset, respectively. The composition of immune cells was different between the high‐ and low‐risk group. The GSEA result suggests that genes of the patients in low‐risk group were mainly enriched in the DNA adducts; drug metabolism‐cytochrome P450, metabolism of xenobiotics by cytochrome P450. CONCLUSION: This study identified DDR‐associated potential biomarkers related to overall survival of LUSC and establishes the DDR‐associated gene signature. John Wiley & Sons Australia, Ltd 2022-03-15 2022-04 /pmc/articles/PMC9013644/ /pubmed/35293140 http://dx.doi.org/10.1111/1759-7714.14370 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Jia, Bin
Gong, Ting
Sun, Bingsheng
Zhang, Zhenfa
Zhong, Diansheng
Wang, Changli
Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
title Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
title_full Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
title_fullStr Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
title_full_unstemmed Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
title_short Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
title_sort identification of a dna damage repair gene‐related signature for lung squamous cell carcinoma prognosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013644/
https://www.ncbi.nlm.nih.gov/pubmed/35293140
http://dx.doi.org/10.1111/1759-7714.14370
work_keys_str_mv AT jiabin identificationofadnadamagerepairgenerelatedsignatureforlungsquamouscellcarcinomaprognosis
AT gongting identificationofadnadamagerepairgenerelatedsignatureforlungsquamouscellcarcinomaprognosis
AT sunbingsheng identificationofadnadamagerepairgenerelatedsignatureforlungsquamouscellcarcinomaprognosis
AT zhangzhenfa identificationofadnadamagerepairgenerelatedsignatureforlungsquamouscellcarcinomaprognosis
AT zhongdiansheng identificationofadnadamagerepairgenerelatedsignatureforlungsquamouscellcarcinomaprognosis
AT wangchangli identificationofadnadamagerepairgenerelatedsignatureforlungsquamouscellcarcinomaprognosis